[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Buparlisib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

February 2023 | 114 pages | ID: G364D4A197B9EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Buparlisib is an orally bioavailable and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor.

According to our (Global Info Research) latest study, the global Buparlisib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Buparlisib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Buparlisib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029

Global Buparlisib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029

Global Buparlisib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029

Global Buparlisib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Buparlisib

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Buparlisib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Selleck Chemicals, Abcam, BOC Sciences, Syd Labs and Santa Cruz Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Buparlisib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Min Purity Less Than 98%
  • Min Purity 98%-99%
  • Min Purity More Than 99%
Market segment by Application
  • Research
  • Medical
Major players covered
  • Selleck Chemicals
  • Abcam
  • BOC Sciences
  • Syd Labs
  • Santa Cruz Biotechnology
  • Cayman Chemical
  • BioVision
  • Shimadzu
  • Biosynth Carbosynth
  • Adooq Bioscience
  • Axon Medchem
  • TargetMol
  • Enzo Biochem
  • LGC
  • LKT Laboratories
  • InvivoChem
  • J&K Scientific
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Buparlisib product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Buparlisib, with price, sales, revenue and global market share of Buparlisib from 2018 to 2023.

Chapter 3, the Buparlisib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Buparlisib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Buparlisib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Buparlisib.

Chapter 14 and 15, to describe Buparlisib sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Buparlisib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Buparlisib Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Min Purity Less Than 98%
  1.3.3 Min Purity 98%-99%
  1.3.4 Min Purity More Than 99%
1.4 Market Analysis by Application
  1.4.1 Overview: Global Buparlisib Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Research
  1.4.3 Medical
1.5 Global Buparlisib Market Size & Forecast
  1.5.1 Global Buparlisib Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Buparlisib Sales Quantity (2018-2029)
  1.5.3 Global Buparlisib Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Selleck Chemicals
  2.1.1 Selleck Chemicals Details
  2.1.2 Selleck Chemicals Major Business
  2.1.3 Selleck Chemicals Buparlisib Product and Services
  2.1.4 Selleck Chemicals Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Selleck Chemicals Recent Developments/Updates
2.2 Abcam
  2.2.1 Abcam Details
  2.2.2 Abcam Major Business
  2.2.3 Abcam Buparlisib Product and Services
  2.2.4 Abcam Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Abcam Recent Developments/Updates
2.3 BOC Sciences
  2.3.1 BOC Sciences Details
  2.3.2 BOC Sciences Major Business
  2.3.3 BOC Sciences Buparlisib Product and Services
  2.3.4 BOC Sciences Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 BOC Sciences Recent Developments/Updates
2.4 Syd Labs
  2.4.1 Syd Labs Details
  2.4.2 Syd Labs Major Business
  2.4.3 Syd Labs Buparlisib Product and Services
  2.4.4 Syd Labs Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Syd Labs Recent Developments/Updates
2.5 Santa Cruz Biotechnology
  2.5.1 Santa Cruz Biotechnology Details
  2.5.2 Santa Cruz Biotechnology Major Business
  2.5.3 Santa Cruz Biotechnology Buparlisib Product and Services
  2.5.4 Santa Cruz Biotechnology Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Santa Cruz Biotechnology Recent Developments/Updates
2.6 Cayman Chemical
  2.6.1 Cayman Chemical Details
  2.6.2 Cayman Chemical Major Business
  2.6.3 Cayman Chemical Buparlisib Product and Services
  2.6.4 Cayman Chemical Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Cayman Chemical Recent Developments/Updates
2.7 BioVision
  2.7.1 BioVision Details
  2.7.2 BioVision Major Business
  2.7.3 BioVision Buparlisib Product and Services
  2.7.4 BioVision Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 BioVision Recent Developments/Updates
2.8 Shimadzu
  2.8.1 Shimadzu Details
  2.8.2 Shimadzu Major Business
  2.8.3 Shimadzu Buparlisib Product and Services
  2.8.4 Shimadzu Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Shimadzu Recent Developments/Updates
2.9 Biosynth Carbosynth
  2.9.1 Biosynth Carbosynth Details
  2.9.2 Biosynth Carbosynth Major Business
  2.9.3 Biosynth Carbosynth Buparlisib Product and Services
  2.9.4 Biosynth Carbosynth Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Biosynth Carbosynth Recent Developments/Updates
2.10 Adooq Bioscience
  2.10.1 Adooq Bioscience Details
  2.10.2 Adooq Bioscience Major Business
  2.10.3 Adooq Bioscience Buparlisib Product and Services
  2.10.4 Adooq Bioscience Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Adooq Bioscience Recent Developments/Updates
2.11 Axon Medchem
  2.11.1 Axon Medchem Details
  2.11.2 Axon Medchem Major Business
  2.11.3 Axon Medchem Buparlisib Product and Services
  2.11.4 Axon Medchem Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Axon Medchem Recent Developments/Updates
2.12 TargetMol
  2.12.1 TargetMol Details
  2.12.2 TargetMol Major Business
  2.12.3 TargetMol Buparlisib Product and Services
  2.12.4 TargetMol Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 TargetMol Recent Developments/Updates
2.13 Enzo Biochem
  2.13.1 Enzo Biochem Details
  2.13.2 Enzo Biochem Major Business
  2.13.3 Enzo Biochem Buparlisib Product and Services
  2.13.4 Enzo Biochem Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 Enzo Biochem Recent Developments/Updates
2.14 LGC
  2.14.1 LGC Details
  2.14.2 LGC Major Business
  2.14.3 LGC Buparlisib Product and Services
  2.14.4 LGC Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 LGC Recent Developments/Updates
2.15 LKT Laboratories
  2.15.1 LKT Laboratories Details
  2.15.2 LKT Laboratories Major Business
  2.15.3 LKT Laboratories Buparlisib Product and Services
  2.15.4 LKT Laboratories Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.15.5 LKT Laboratories Recent Developments/Updates
2.16 InvivoChem
  2.16.1 InvivoChem Details
  2.16.2 InvivoChem Major Business
  2.16.3 InvivoChem Buparlisib Product and Services
  2.16.4 InvivoChem Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.16.5 InvivoChem Recent Developments/Updates
2.17 J&K Scientific
  2.17.1 J&K Scientific Details
  2.17.2 J&K Scientific Major Business
  2.17.3 J&K Scientific Buparlisib Product and Services
  2.17.4 J&K Scientific Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.17.5 J&K Scientific Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: BUPARLISIB BY MANUFACTURER

3.1 Global Buparlisib Sales Quantity by Manufacturer (2018-2023)
3.2 Global Buparlisib Revenue by Manufacturer (2018-2023)
3.3 Global Buparlisib Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Buparlisib by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Buparlisib Manufacturer Market Share in 2022
  3.4.2 Top 6 Buparlisib Manufacturer Market Share in 2022
3.5 Buparlisib Market: Overall Company Footprint Analysis
  3.5.1 Buparlisib Market: Region Footprint
  3.5.2 Buparlisib Market: Company Product Type Footprint
  3.5.3 Buparlisib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Buparlisib Market Size by Region
  4.1.1 Global Buparlisib Sales Quantity by Region (2018-2029)
  4.1.2 Global Buparlisib Consumption Value by Region (2018-2029)
  4.1.3 Global Buparlisib Average Price by Region (2018-2029)
4.2 North America Buparlisib Consumption Value (2018-2029)
4.3 Europe Buparlisib Consumption Value (2018-2029)
4.4 Asia-Pacific Buparlisib Consumption Value (2018-2029)
4.5 South America Buparlisib Consumption Value (2018-2029)
4.6 Middle East and Africa Buparlisib Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Buparlisib Sales Quantity by Type (2018-2029)
5.2 Global Buparlisib Consumption Value by Type (2018-2029)
5.3 Global Buparlisib Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Buparlisib Sales Quantity by Application (2018-2029)
6.2 Global Buparlisib Consumption Value by Application (2018-2029)
6.3 Global Buparlisib Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Buparlisib Sales Quantity by Type (2018-2029)
7.2 North America Buparlisib Sales Quantity by Application (2018-2029)
7.3 North America Buparlisib Market Size by Country
  7.3.1 North America Buparlisib Sales Quantity by Country (2018-2029)
  7.3.2 North America Buparlisib Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Buparlisib Sales Quantity by Type (2018-2029)
8.2 Europe Buparlisib Sales Quantity by Application (2018-2029)
8.3 Europe Buparlisib Market Size by Country
  8.3.1 Europe Buparlisib Sales Quantity by Country (2018-2029)
  8.3.2 Europe Buparlisib Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Buparlisib Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Buparlisib Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Buparlisib Market Size by Region
  9.3.1 Asia-Pacific Buparlisib Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Buparlisib Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Buparlisib Sales Quantity by Type (2018-2029)
10.2 South America Buparlisib Sales Quantity by Application (2018-2029)
10.3 South America Buparlisib Market Size by Country
  10.3.1 South America Buparlisib Sales Quantity by Country (2018-2029)
  10.3.2 South America Buparlisib Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Buparlisib Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Buparlisib Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Buparlisib Market Size by Country
  11.3.1 Middle East & Africa Buparlisib Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Buparlisib Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Buparlisib Market Drivers
12.2 Buparlisib Market Restraints
12.3 Buparlisib Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Buparlisib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Buparlisib
13.3 Buparlisib Production Process
13.4 Buparlisib Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Buparlisib Typical Distributors
14.3 Buparlisib Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Buparlisib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Buparlisib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Selleck Chemicals Basic Information, Manufacturing Base and Competitors
Table 4. Selleck Chemicals Major Business
Table 5. Selleck Chemicals Buparlisib Product and Services
Table 6. Selleck Chemicals Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Selleck Chemicals Recent Developments/Updates
Table 8. Abcam Basic Information, Manufacturing Base and Competitors
Table 9. Abcam Major Business
Table 10. Abcam Buparlisib Product and Services
Table 11. Abcam Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Abcam Recent Developments/Updates
Table 13. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 14. BOC Sciences Major Business
Table 15. BOC Sciences Buparlisib Product and Services
Table 16. BOC Sciences Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BOC Sciences Recent Developments/Updates
Table 18. Syd Labs Basic Information, Manufacturing Base and Competitors
Table 19. Syd Labs Major Business
Table 20. Syd Labs Buparlisib Product and Services
Table 21. Syd Labs Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Syd Labs Recent Developments/Updates
Table 23. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Santa Cruz Biotechnology Major Business
Table 25. Santa Cruz Biotechnology Buparlisib Product and Services
Table 26. Santa Cruz Biotechnology Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Santa Cruz Biotechnology Recent Developments/Updates
Table 28. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 29. Cayman Chemical Major Business
Table 30. Cayman Chemical Buparlisib Product and Services
Table 31. Cayman Chemical Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cayman Chemical Recent Developments/Updates
Table 33. BioVision Basic Information, Manufacturing Base and Competitors
Table 34. BioVision Major Business
Table 35. BioVision Buparlisib Product and Services
Table 36. BioVision Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. BioVision Recent Developments/Updates
Table 38. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 39. Shimadzu Major Business
Table 40. Shimadzu Buparlisib Product and Services
Table 41. Shimadzu Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shimadzu Recent Developments/Updates
Table 43. Biosynth Carbosynth Basic Information, Manufacturing Base and Competitors
Table 44. Biosynth Carbosynth Major Business
Table 45. Biosynth Carbosynth Buparlisib Product and Services
Table 46. Biosynth Carbosynth Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Biosynth Carbosynth Recent Developments/Updates
Table 48. Adooq Bioscience Basic Information, Manufacturing Base and Competitors
Table 49. Adooq Bioscience Major Business
Table 50. Adooq Bioscience Buparlisib Product and Services
Table 51. Adooq Bioscience Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Adooq Bioscience Recent Developments/Updates
Table 53. Axon Medchem Basic Information, Manufacturing Base and Competitors
Table 54. Axon Medchem Major Business
Table 55. Axon Medchem Buparlisib Product and Services
Table 56. Axon Medchem Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Axon Medchem Recent Developments/Updates
Table 58. TargetMol Basic Information, Manufacturing Base and Competitors
Table 59. TargetMol Major Business
Table 60. TargetMol Buparlisib Product and Services
Table 61. TargetMol Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. TargetMol Recent Developments/Updates
Table 63. Enzo Biochem Basic Information, Manufacturing Base and Competitors
Table 64. Enzo Biochem Major Business
Table 65. Enzo Biochem Buparlisib Product and Services
Table 66. Enzo Biochem Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Enzo Biochem Recent Developments/Updates
Table 68. LGC Basic Information, Manufacturing Base and Competitors
Table 69. LGC Major Business
Table 70. LGC Buparlisib Product and Services
Table 71. LGC Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. LGC Recent Developments/Updates
Table 73. LKT Laboratories Basic Information, Manufacturing Base and Competitors
Table 74. LKT Laboratories Major Business
Table 75. LKT Laboratories Buparlisib Product and Services
Table 76. LKT Laboratories Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. LKT Laboratories Recent Developments/Updates
Table 78. InvivoChem Basic Information, Manufacturing Base and Competitors
Table 79. InvivoChem Major Business
Table 80. InvivoChem Buparlisib Product and Services
Table 81. InvivoChem Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. InvivoChem Recent Developments/Updates
Table 83. J&K Scientific Basic Information, Manufacturing Base and Competitors
Table 84. J&K Scientific Major Business
Table 85. J&K Scientific Buparlisib Product and Services
Table 86. J&K Scientific Buparlisib Sales Quantity (Kg), Average Price (K USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. J&K Scientific Recent Developments/Updates
Table 88. Global Buparlisib Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 89. Global Buparlisib Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Buparlisib Average Price by Manufacturer (2018-2023) & (K USD/Kg)
Table 91. Market Position of Manufacturers in Buparlisib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Buparlisib Production Site of Key Manufacturer
Table 93. Buparlisib Market: Company Product Type Footprint
Table 94. Buparlisib Market: Company Product Application Footprint
Table 95. Buparlisib New Market Entrants and Barriers to Market Entry
Table 96. Buparlisib Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Buparlisib Sales Quantity by Region (2018-2023) & (Kg)
Table 98. Global Buparlisib Sales Quantity by Region (2024-2029) & (Kg)
Table 99. Global Buparlisib Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Buparlisib Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Buparlisib Average Price by Region (2018-2023) & (K USD/Kg)
Table 102. Global Buparlisib Average Price by Region (2024-2029) & (K USD/Kg)
Table 103. Global Buparlisib Sales Quantity by Type (2018-2023) & (Kg)
Table 104. Global Buparlisib Sales Quantity by Type (2024-2029) & (Kg)
Table 105. Global Buparlisib Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Buparlisib Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Buparlisib Average Price by Type (2018-2023) & (K USD/Kg)
Table 108. Global Buparlisib Average Price by Type (2024-2029) & (K USD/Kg)
Table 109. Global Buparlisib Sales Quantity by Application (2018-2023) & (Kg)
Table 110. Global Buparlisib Sales Quantity by Application (2024-2029) & (Kg)
Table 111. Global Buparlisib Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Buparlisib Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Buparlisib Average Price by Application (2018-2023) & (K USD/Kg)
Table 114. Global Buparlisib Average Price by Application (2024-2029) & (K USD/Kg)
Table 115. North America Buparlisib Sales Quantity by Type (2018-2023) & (Kg)
Table 116. North America Buparlisib Sales Quantity by Type (2024-2029) & (Kg)
Table 117. North America Buparlisib Sales Quantity by Application (2018-2023) & (Kg)
Table 118. North America Buparlisib Sales Quantity by Application (2024-2029) & (Kg)
Table 119. North America Buparlisib Sales Quantity by Country (2018-2023) & (Kg)
Table 120. North America Buparlisib Sales Quantity by Country (2024-2029) & (Kg)
Table 121. North America Buparlisib Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Buparlisib Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Buparlisib Sales Quantity by Type (2018-2023) & (Kg)
Table 124. Europe Buparlisib Sales Quantity by Type (2024-2029) & (Kg)
Table 125. Europe Buparlisib Sales Quantity by Application (2018-2023) & (Kg)
Table 126. Europe Buparlisib Sales Quantity by Application (2024-2029) & (Kg)
Table 127. Europe Buparlisib Sales Quantity by Country (2018-2023) & (Kg)
Table 128. Europe Buparlisib Sales Quantity by Country (2024-2029) & (Kg)
Table 129. Europe Buparlisib Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Buparlisib Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Buparlisib Sales Quantity by Type (2018-2023) & (Kg)
Table 132. Asia-Pacific Buparlisib Sales Quantity by Type (2024-2029) & (Kg)
Table 133. Asia-Pacific Buparlisib Sales Quantity by Application (2018-2023) & (Kg)
Table 134. Asia-Pacific Buparlisib Sales Quantity by Application (2024-2029) & (Kg)
Table 135. Asia-Pacific Buparlisib Sales Quantity by Region (2018-2023) & (Kg)
Table 136. Asia-Pacific Buparlisib Sales Quantity by Region (2024-2029) & (Kg)
Table 137. Asia-Pacific Buparlisib Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Buparlisib Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Buparlisib Sales Quantity by Type (2018-2023) & (Kg)
Table 140. South America Buparlisib Sales Quantity by Type (2024-2029) & (Kg)
Table 141. South America Buparlisib Sales Quantity by Application (2018-2023) & (Kg)
Table 142. South America Buparlisib Sales Quantity by Application (2024-2029) & (Kg)
Table 143. South America Buparlisib Sales Quantity by Country (2018-2023) & (Kg)
Table 144. South America Buparlisib Sales Quantity by Country (2024-2029) & (Kg)
Table 145. South America Buparlisib Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Buparlisib Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Buparlisib Sales Quantity by Type (2018-2023) & (Kg)
Table 148. Middle East & Africa Buparlisib Sales Quantity by Type (2024-2029) & (Kg)
Table 149. Middle East & Africa Buparlisib Sales Quantity by Application (2018-2023) & (Kg)
Table 150. Middle East & Africa Buparlisib Sales Quantity by Application (2024-2029) & (Kg)
Table 151. Middle East & Africa Buparlisib Sales Quantity by Region (2018-2023) & (Kg)
Table 152. Middle East & Africa Buparlisib Sales Quantity by Region (2024-2029) & (Kg)
Table 153. Middle East & Africa Buparlisib Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Buparlisib Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Buparlisib Raw Material
Table 156. Key Manufacturers of Buparlisib Raw Materials
Table 157. Buparlisib Typical Distributors
Table 158. Buparlisib Typical Customers

LIST OF FIGURES

Figure 1. Buparlisib Picture
Figure 2. Global Buparlisib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Buparlisib Consumption Value Market Share by Type in 2022
Figure 4. Min Purity Less Than 98% Examples
Figure 5. Min Purity 98%-99% Examples
Figure 6. Min Purity More Than 99% Examples
Figure 7. Global Buparlisib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Buparlisib Consumption Value Market Share by Application in 2022
Figure 9. Research Examples
Figure 10. Medical Examples
Figure 11. Global Buparlisib Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Buparlisib Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Buparlisib Sales Quantity (2018-2029) & (Kg)
Figure 14. Global Buparlisib Average Price (2018-2029) & (K USD/Kg)
Figure 15. Global Buparlisib Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Buparlisib Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Buparlisib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Buparlisib Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Buparlisib Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Buparlisib Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Buparlisib Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Buparlisib Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Buparlisib Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Buparlisib Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Buparlisib Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Buparlisib Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Buparlisib Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Buparlisib Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Buparlisib Average Price by Type (2018-2029) & (K USD/Kg)
Figure 30. Global Buparlisib Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Buparlisib Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Buparlisib Average Price by Application (2018-2029) & (K USD/Kg)
Figure 33. North America Buparlisib Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Buparlisib Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Buparlisib Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Buparlisib Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Buparlisib Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Buparlisib Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Buparlisib Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Buparlisib Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Buparlisib Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Buparlisib Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Buparlisib Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Buparlisib Consumption Value Market Share by Region (2018-2029)
Figure 53. China Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Buparlisib Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Buparlisib Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Buparlisib Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Buparlisib Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Buparlisib Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Buparlisib Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Buparlisib Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Buparlisib Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Buparlisib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Buparlisib Market Drivers
Figure 74. Buparlisib Market Restraints
Figure 75. Buparlisib Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Buparlisib in 2022
Figure 78. Manufacturing Process Analysis of Buparlisib
Figure 79. Buparlisib Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications